ArticleLasers in medical science2025
Application of Z-scan technique in detecting circulating free DNA for prostate cancer diagnosis and monitoring.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review.Frontiers in oncology · 2026Pooled it
- A novel insight into the femtosecond induced nonlinear response of monoamine neurotransmitters through experimental and in silico approaches.Scientific reports · 2025Article
- Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Prostate cancer diagnosis relies on methods like PSA testing, digital rectal exams, and biopsies. The Z-scan technique, a nonlinear optical method, may provide a new, non-invasive approach to detecting circulating free DNA (ccfDNA) in serum, offering potential improvements in cancer diagnosis and monitoring. The aim of this study is to evaluate whether the Z-scan technique can serve as an alternative or complementary diagnostic tool to existing prostate cancer tests. The Z-scan technique was applied to detect apoptotic and necrotic ccfDNA fragments in the serum or plasma of prostate cancer patients. This technique measures the nonlinear refractive index's dispersive and absorptive components and was compared with laboratory data, such as PSA levels and cancer progression indicators. The study found a correlation between Z-scan-derived θ values and PSA levels, suggesting its utility in identifying cancer relapse. However, no correlation was observed with the Gleason scale. The Z-scan technique shows promise as a diagnostic and monitoring tool for prostate cancer, offering a potential non-invasive alternative to traditional methods.
Indexed as
Identifiers
39984815What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.